From a Fledgling Genetic Science, A Murky Market for Predictions
By Ashley Smart,
Undark
| 10. 27. 2023
To Hear Kian Sadeghi tell it, his genetic testing company just might upend health care. The 23-year-old college dropout began working on Nucleus in 2020, from his bedroom in his parents’ Brooklyn home. From a swab of genetic material, he says, his company can glean insights into which drugs a person should be prescribed, which diet will best help them lose weight, and how concerned they should be about getting Alzheimer’s, among many other health considerations.
Sadeghi has received millions of dollars in financial backing from some of the most influential figures in Silicon Valley, including venture capital firms led by Reddit co-founder Alexis Ohanian and billionaire Peter Thiel. “It’s an inevitability that every single person has their entire human genome on their iPhone,” Sadeghi told Ohanian in a promotional video released on X, the platform formerly known as Twitter, in July 2022. “Who’s going to analyze it? Who’s going to store it? Who’s going to maintain it?” he said. “It’s going to be Nucleus.”
Sadeghi, who studied computational biology during his year-and-a-half as an undergraduate, asserts that he can...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...